Animal Parasiticides Sales

Animal Parasiticides Sales Market Outlook

The global Animal Parasiticides Sales Market was valued at approximately USD 4.2 billion in 2023 and is projected to reach around USD 6.8 billion by 2035, exhibiting a robust CAGR of 5.5% throughout the forecast period. The increasing incidences of parasitic infections in both companion and livestock animals have significantly contributed to this market growth. Moreover, the growing awareness about animal health and the rising demand for high-quality animal products are driving factors. The advancements in veterinary pharmaceuticals, coupled with an increase in the number of veterinary practitioners worldwide, are further stimulating market expansion. Additionally, the surge in pet ownership, particularly in developing regions, is expected to provide a substantial impetus to the animal parasiticides market.

Growth Factor of the Market

The growth of the Animal Parasiticides Sales Market can be attributed to several factors that underscore its significance in modern veterinary care. Firstly, the rise in global livestock production, driven by an increasing demand for animal-derived food products, has necessitated effective parasite control measures to ensure livestock health and productivity. Secondly, the growing trend of pet ownership, especially during the post-pandemic era, has led to increased spending on pet healthcare, including preventative treatments against parasites. Furthermore, innovations in product formulations and the development of more effective and safer parasiticides have bolstered adoption rates among veterinarians and pet owners alike. The emergence of online sales platforms has also played a crucial role in expanding product accessibility, facilitating convenient purchasing processes for consumers. Lastly, the heightened awareness about zoonotic diseases has propelled the market for animal parasiticides as a preventive health measure.

Key Highlights of the Market

• The Animal Parasiticides Sales Market is expected to witness a significant growth rate of 5.5% from 2025 to 2035.
• Increasing incidences of parasitic infections in both livestock and companion animals are driving the market demand.
• Technological advancements in veterinary pharmaceuticals are improving the efficacy and safety of parasiticides.
• The rise in pet ownership and spending on animal healthcare is contributing to market expansion.
• Online distribution channels are increasingly popular, providing greater accessibility to parasiticides.

By Product Type

Ectoparasiticides:

Ectoparasiticides are a crucial segment of the animal parasiticides market, designed specifically to target external parasites such as fleas, ticks, and mites that infest companion and livestock animals. These products are formulated to either eliminate existing infestations or prevent future occurrences. The growing prevalence of ectoparasites, especially in warmer climates, is a significant driver for this segment. Moreover, the increasing awareness about the impact of ectoparasitic infections on the overall health and productivity of animals has led to a heightened demand for effective ectoparasiticides. Innovations in this category, including spot-on treatments and long-acting formulations, have improved user compliance and efficacy, further propelling market growth in this area.

Endoparasiticides:

Endoparasiticides play a vital role in the management of internal parasites, such as worms and protozoa, that affect the gastrointestinal health of animals. This segment is especially important for livestock, where parasitic infections can severely impact growth rates and overall productivity. The increasing focus on improving animal welfare and productivity in the agricultural sector has fueled the demand for effective endoparasiticides. Furthermore, the rise in awareness regarding the health risks associated with untreated internal parasites has led farmers and pet owners to prioritize the use of these products. Advances in drug formulations, which enhance the effectiveness and reduce side effects, are expected to bolster this segment considerably over the coming years.

Endectocides:

Endectocides are comprehensive parasiticides that can target both external and internal parasites, making them a versatile choice for animal health management. This segment is gaining traction due to the growing recognition of the interconnectedness of parasite types and the need for comprehensive treatment solutions. Endectocides are particularly popular in livestock, where multi-parasitic infections are common. The increasing demand for integrated pest management solutions in veterinary care is also pushing the growth of this segment. Additionally, the development of long-acting endectocides has improved convenience for animal owners, further driving their popularity and adoption in the market.

Oral Liquids:

Oral liquid formulations of parasiticides are favored for their ease of administration, particularly in younger animals or those that are difficult to treat with other methods. This product type is particularly prevalent in both companion animals and livestock. The liquid form allows for accurate dosing and is often more palatable than tablets or powders, leading to better compliance among pet owners and farmers alike. The segment has seen growth due to the increasing trend toward preventive healthcare, as oral liquids are commonly used for routine deworming. Moreover, innovations in flavoring and formulation are enhancing the appeal of oral liquids, making them a popular choice among veterinarians and animal caregivers.

Spray:

Sprays are an effective delivery method for topical treatment of external parasites and are widely used in both companion and livestock animals. This product type is gaining popularity due to its ease of application and immediate action against infestations. Sprays can cover large areas of the animal's body, making them particularly effective for large livestock where other forms of administration may be impractical. The ongoing development of user-friendly spray formulations, including those that are non-toxic and environmentally friendly, is expected to further fuel growth in this segment. Additionally, the rise in professional grooming and animal care services has contributed to the increased sales of parasiticidal sprays.

Spot-on:

Spot-on treatments are a highly convenient and efficient method for administering parasiticides, particularly for companion animals. This product type is applied topically at a specific location on the animal's skin, allowing for localized treatment that is effective against a variety of parasites. Spot-on products are particularly favored for their ease of use and minimal stress for the animals during application. The growing trend of pet ownership, alongside increased consumer awareness of the risks posed by parasites, has driven the demand for spot-on solutions. Furthermore, manufacturers are increasingly introducing long-lasting formulations to ensure extended protection, enhancing their appeal to pet owners.

Others:

This category encompasses various other forms of parasiticidal products that don't fit neatly into the aforementioned segments, including powders, gels, and medicated collars. While smaller in market share compared to other product types, these alternatives provide additional options that cater to specific needs and preferences of pet owners and livestock managers. The diversity of formulations is essential in addressing the varying requirements across different animal types and environments. As consumer preference shifts towards tailored healthcare solutions, the "Others" segment is expected to gradually expand, driven by innovation and specialized products that enhance animal welfare and health.

By Animal Type

Companion Animals:

The companion animals segment is one of the most lucrative sectors in the animal parasiticides market, driven primarily by the increasing trend of pet ownership worldwide. Dogs and cats, as the primary focus of this segment, require regular treatment for a variety of parasites, including fleas, ticks, and intestinal worms. The heightened awareness among pet owners regarding the health risks posed by these parasites has led to increased spending on preventive healthcare products. Additionally, the emotional and financial investments that pet owners make in their pets' health drive consistent demand for effective parasiticidal treatments. The companion animal market is also benefiting from innovations in product formulations tailored to the unique needs of different breeds and life stages.

Livestock Animals:

The livestock animals segment represents a critical component of the animal parasiticides market, as effective parasite control is essential for maintaining animal health and productivity in agricultural operations. This segment encompasses a wide range of species, including cattle, sheep, and pigs, and is driven by the need for high-quality meat, milk, and other animal products. The increasing global demand for these products has necessitated the implementation of rigorous parasite control measures within the livestock sector. Furthermore, the rising focus on organic and sustainable farming practices is influencing the livestock market, as producers seek effective yet environmentally friendly parasiticidal solutions. The integration of advanced veterinary practices and the development of multi-parasiticidal products are expected to boost this segment significantly.

Poultry:

The poultry segment is a rapidly growing area of the animal parasiticides market, particularly in regions where poultry farming plays a crucial role in food production. This segment is characterized by a need for effective control of intestinal and external parasites that can severely affect the health and productivity of birds. The increasing demand for poultry products, driven by population growth and changing dietary preferences, is fueling the need for reliable parasiticidal solutions. Additionally, the implementation of biosecurity measures in poultry farming has led to heightened awareness of the risks posed by parasites, prompting farmers to invest in effective parasiticidal treatments. The development of specialized products tailored to the unique needs of poultry is expected to further enhance growth in this segment.

Aquaculture:

The aquaculture segment is an emerging area of growth within the animal parasiticides market, driven by the increasing global demand for fish and seafood products. As aquaculture operations expand, the management of parasitic infections in fish and other aquatic species has become increasingly important. Effective parasiticidal treatments are essential for maintaining the health of aquaculture species and ensuring high yields. The rising awareness of the economic impact of parasitic infections on aquaculture production has led to a growing demand for effective and safe parasiticides. Furthermore, the development of targeted treatments that minimize environmental impact while maximizing efficacy is expected to drive innovation and growth in this segment, appealing to both producers and consumers concerned about sustainability.

By Route of Administration

Oral:

The oral route of administration is one of the most common methods for delivering parasiticides to animals, favored for its convenience and ease of use. This method typically involves the use of tablets, powders, or liquids that can be easily mixed into an animal's food or administered directly. The oral segment is especially significant in the livestock and companion animal markets, as it allows for accurate dosing and ensures that the animals receive the full therapeutic benefit. The growing trend of preventive healthcare among pet owners and livestock farmers is further driving demand for oral parasiticides, as this route allows for routine deworming and maintenance of overall health. Additionally, the development of palatable formulations is enhancing compliance and encouraging regular use.

Topical:

The topical route of administration involves applying parasiticides directly onto the skin of the animal, providing a targeted approach to treating external parasites such as fleas and ticks. This method is particularly popular among pet owners for its ease of application and immediate action against infestations. Products such as spot-on treatments and sprays have gained significant traction in the companion animal segment due to their effectiveness and convenience. With increasing consumer awareness about the importance of regular pest control in maintaining animal health, the demand for topical formulations has surged. Moreover, innovations in long-lasting formulations that offer extended protection are expected to further boost this segment's growth, appealing to pet owners seeking efficient and effective solutions.

Parenteral:

The parenteral route of administration involves injecting parasiticides directly into the animal, typically via subcutaneous or intramuscular routes. This method is commonly employed in livestock and is favored for its rapid absorption and effectiveness against a wide range of parasites. The parenteral segment is crucial for managing severe infestations or in cases where immediate action is required. The increasing adoption of veterinary practices that prioritize optimal animal health and welfare is driving demand for injectable parasiticides. Furthermore, advancements in formulation technologies are leading to the development of long-acting parenteral products that offer sustained protection, enhancing their use in both livestock and companion animals.

Others:

The "Others" category encompasses various less common routes of administration for parasiticides, such as intranasal or ocular applications. While this segment represents a smaller share of the overall market, it offers specialized solutions for specific parasitic challenges that may not be effectively addressed through the more traditional routes. Innovations in drug delivery systems are fostering the development of new products in this category, catering to niche markets and unique animal health needs. The growth of this segment is expected to be driven by increasing investments in research and development aimed at improving the efficacy and safety of parasiticidal treatments.

By Distribution Channel

Veterinary Hospitals:

Veterinary hospitals play a pivotal role in the distribution of animal parasiticides, serving as primary care facilities for companion and livestock animals. This channel is characterized by professional recommendations from veterinarians, ensuring that pet owners and farmers receive the most appropriate treatments for their animals. The trust that consumers place in veterinary hospitals enhances the adoption rates of prescribed parasiticidal products. Additionally, the availability of a wide range of formulations, including those that are newly launched or specialized, makes veterinary hospitals a key distribution channel. The growing emphasis on regular veterinary check-ups and preventive healthcare is expected to drive this segment's growth, as pet owners and livestock managers seek professional guidance to maintain animal health.

Veterinary Clinics:

Veterinary clinics are another crucial distribution channel for animal parasiticides, providing accessible healthcare services for pets and farm animals alike. These clinics often cater to a diverse clientele, including routine check-ups and treatments for parasitic infections. The convenience and personalized care offered by veterinary clinics enhance customer loyalty and increase the likelihood of regular purchases of parasiticidal products. Moreover, the growing trend of preventive care is influencing the sales of parasiticides through clinics, as pet owners become more proactive about their animals' health. Ongoing partnerships between veterinary clinics and pharmaceutical companies are expected to bolster this distribution channel, leading to a wider range of available products.

Pharmacies & Drug Stores:

Pharmacies and drug stores serve as accessible retail outlets for animal parasiticides, particularly in urban areas where pet ownership is high. This distribution channel offers consumers the convenience of purchasing parasiticidal products over the counter without needing a veterinarian's prescription. The growing trend of self-medication among pet owners has led to increased sales through pharmacies and drug stores, as consumers seek effective solutions for common parasitic issues. Furthermore, the expansion of pharmacy chains to include pet health products has enhanced product availability, making it easier for consumers to find the treatments they need. The rise in awareness about animal health and wellness is expected to further boost this distribution channel's growth in the coming years.

Online Pharmacies:

Online pharmacies have emerged as a significant distribution channel for animal parasiticides, particularly in the wake of the digital transformation and changes in consumer purchasing behavior. The convenience of online shopping allows consumers to access a wide range of parasiticidal products from the comfort of their homes, often at competitive prices. This channel has gained popularity due to its ability to provide detailed product information and consumer reviews, fostering informed purchasing decisions. The COVID-19 pandemic has accelerated the shift towards online shopping, with many pet owners opting for remote purchasing to ensure their pets' health while minimizing exposure to crowds. The continued growth of e-commerce is expected to bolster the online pharmacy segment, as more consumers embrace the ease and convenience of digital transactions.

By Region

The North America region holds a significant share of the Animal Parasiticides Sales Market, with the United States leading due to its advanced veterinary healthcare infrastructure and high pet ownership rates. The market in this region is projected to grow at a CAGR of approximately 5.2% from 2025 to 2035, fueled by increasing awareness of animal health and safety regulations. The rising incidence of zoonotic diseases, coupled with a growing demand for organic and sustainable farming practices, is influencing the market dynamics. Additionally, the presence of major market players and ongoing research and development activities are expected to drive innovation and product offerings in the North American market.

In Europe, the animal parasiticides market is characterized by stringent regulations regarding animal health and safety, which are driving growth in the sector. Countries such as Germany, France, and the United Kingdom are witnessing increased investments in veterinary services and pharmaceuticals, contributing to market expansion. The European market is expected to grow at a CAGR of 5.8%, with a notable increase in the demand for eco-friendly and sustainable parasiticidal products. The rising concern over animal welfare and the growing trend of pet ownership are further propelling the growth of the market in this region. Ongoing advancements in veterinary technologies and increasing consumer education about parasitic control are also expected to foster growth.

Opportunities

The Animal Parasiticides Sales Market presents numerous opportunities for growth, particularly as consumer preferences shift toward preventive healthcare measures. As pet ownership continues to rise globally, there is a growing demand for effective and convenient solutions to manage parasitic risks. This trend creates opportunities for manufacturers to innovate and introduce new product formulations that cater to the specific needs of different animal types, including specialized treatments for senior pets or those with underlying health conditions. Furthermore, the increasing popularity of online shopping provides an avenue for companies to reach a wider audience and expand their market presence. By leveraging digital marketing strategies and establishing strong online distribution channels, companies can effectively engage with pet owners and livestock producers, driving sales growth.

Another promising opportunity lies in the development of eco-friendly parasiticides and sustainable farming practices. As consumers become more environmentally conscious, there is a rising demand for products that minimize ecological impact while effectively managing parasites. This trend opens the door for companies to invest in research and development efforts aimed at creating biodegradable formulations and natural alternatives to traditional chemical treatments. Additionally, the integration of technology, such as smart collars or apps for monitoring parasite infestations, presents a unique opportunity for innovation within the animal health sector. By embracing these advancements and aligning with consumer preferences, companies can position themselves competitively in the evolving landscape of the animal parasiticides market.

Threats

While the Animal Parasiticides Sales Market is poised for growth, there are several threats that could impact its trajectory. One significant concern is the increasing resistance of parasites to commonly used treatments, which poses a challenge to effective parasite management. As resistance develops, there is a growing need for research and innovation in the formulation of new and effective products. Additionally, the emergence of alternate therapies and natural remedies may divert consumer attention away from traditional parasiticides, affecting sales. Regulatory hurdles regarding the approval and marketing of new products can also slow down the pace of innovation, limiting market growth. Furthermore, economic factors, such as fluctuations in the agricultural sector or pet care spending, could impact consumer purchasing behavior and market demand.

Another potential restraining factor for the market is the rising costs of veterinary care and medications. As pet owners and livestock producers face increasing financial pressures, there may be a tendency to opt for less expensive alternatives or postpone treatments, which can hinder market growth. Additionally, the competitive landscape is intensifying, with numerous players vying for market share. This competition may lead to price wars that could adversely affect profit margins. Finally, the ongoing impact of global events, such as pandemics or supply chain disruptions, may also pose challenges to market stability and growth potential.

Competitor Outlook

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Virbac
• Ceva Santé Animale
• Heska Corporation
• Dechra Pharmaceuticals
• PetIQ
• Phibro Animal Health
• Vetoquinol
• Neogen Corporation
• Animalcare Group
• Farnam Companies
• Intas Pharmaceuticals

The competitive landscape of the Animal Parasiticides Sales Market is marked by a diverse array of companies ranging from established multinational corporations to emerging players focusing on niche markets. Major companies like Zoetis and Merck Animal Health are at the forefront, leveraging their extensive research and development capabilities to introduce innovative parasiticidal products and maintain a robust market presence. These companies have established strong distribution networks and partnerships with veterinarians, ensuring that their products reach a wide audience. Additionally, their commitment to sustainability and eco-friendly practices is gaining traction among consumers who are increasingly aware of environmental issues.

In contrast, smaller companies such as Animalcare Group and Farnam Companies are carving out their niche by offering specialized products that cater to specific animal types or health conditions. These companies often prioritize customer service and personalized care, allowing them to build loyal customer bases. Furthermore, they may benefit from agility in product development, enabling them to respond quickly to changing market demands and consumer preferences. The emergence of digital platforms and e-commerce has also provided smaller players with opportunities to expand their reach and compete with larger corporations on a more level playing field.

As the market evolves, strategic collaborations and mergers between companies are likely to shape the competitive landscape. For example, partnerships between veterinary clinics and pharmaceutical companies can facilitate the introduction of new products and enhance market access. Additionally, as companies invest more in research and development, the focus on creating effective treatments for resistant parasites will become increasingly critical. The competitive dynamics of the Animal Parasiticides Sales Market will continue to evolve, driven by market trends, consumer preferences, and ongoing advancements in veterinary medicine.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 PetIQ
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Virbac
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Zoetis
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Vetoquinol
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Animalcare Group
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Farnam Companies
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Heska Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Neogen Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Merck Animal Health
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Boehringer Ingelheim
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Elanco Animal Health
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Phibro Animal Health
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Intas Pharmaceuticals
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Dechra Pharmaceuticals
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ceva Santé Animale
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Animal Parasiticides Sales Market, By Animal Type
    • 6.1.1 Companion Animals
    • 6.1.2 Livestock Animals
    • 6.1.3 Poultry
    • 6.1.4 Aquaculture
  • 6.2 Animal Parasiticides Sales Market, By Product Type
    • 6.2.1 Ectoparasiticides
    • 6.2.2 Endoparasiticides
    • 6.2.3 Endectocides
    • 6.2.4 Oral Liquids
    • 6.2.5 Spray
    • 6.2.6 Spot-on
    • 6.2.7 Others
  • 6.3 Animal Parasiticides Sales Market, By Distribution Channel
    • 6.3.1 Veterinary Hospitals
    • 6.3.2 Veterinary Clinics
    • 6.3.3 Pharmacies & Drug Stores
    • 6.3.4 Online Pharmacies
  • 6.4 Animal Parasiticides Sales Market, By Route of Administration
    • 6.4.1 Oral
    • 6.4.2 Topical
    • 6.4.3 Parenteral
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Animal Parasiticides Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Animal Parasiticides Sales market is categorized based on

By Product Type

• Ectoparasiticides
• Endoparasiticides
• Endectocides
• Oral Liquids
• Spray
• Spot-on
• Others

By Animal Type

• Companion Animals
• Livestock Animals
• Poultry
• Aquaculture

By Route of Administration

• Oral
• Topical
• Parenteral
• Others

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Online Pharmacies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Virbac
• Ceva Santé Animale
• Heska Corporation
• Dechra Pharmaceuticals
• PetIQ
• Phibro Animal Health
• Vetoquinol
• Neogen Corporation
• Animalcare Group
• Farnam Companies
• Intas Pharmaceuticals